Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Human |
Target | tumor antigen CTAA16.88 |
Clinical data | |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
![]() ![]() |
Technetium (99mTc) votumumab (trade name HumaSPECT) is a human monoclonal antibody labelled with the radionuclide technetium-99m.[1][2] It was developed for the detection of colorectal tumors, but has never been marketed.[3]
The target of votumumab is CTAA16.88, a complex of cytokeratin polypeptides in the molecular weight range of 35 to 43 kDa, which is expressed in colorectal tumors.[4]
Non-renewal of the marketing authorisation in the European Union
Monoclonal antibodies for tumors
| |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tumor |
| ||||||||||||
|
![]() | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |
![]() | This nuclear medicine article is a stub. You can help Wikipedia by expanding it. |